Heart valve disease
Conditions
Interventions
The new anticoagulation management group:Intelligent early warning system
The traditional anticoagulation management group:None
Sponsors
Hainan General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >=18 years old, both sexes; 2. Patients using anticoagulant drugs; 3. The patient had a smart phone in accordance with the operating environment of the study software program, and was able to use the study software program through guidance.
Exclusion criteria
Exclusion criteria: 1.Patients without indications for antithrombotic drugs;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Death rate;Hospital-acquired bleeding complications in patients on anticoagulation therapy;Thrombotic event;Number of days meeting the standards;Number of qualified attempts;International standardization ratio compliance rate;Disease cure rate;Incidence of serious adverse reactions;The required time to meet the standard;Recurrent disease rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Length of hospital stay;Average cost per unit;Recognition score;Number of days during the perioperative period when anticoagulant drugs were discontinued;The reporting rate of adverse events related to anticoagulant drugs;The number of anticoagulant drugs used during the perioperative period;The total number of anticoagulant drugs used;Indirect costs;Direct expense;The proportion of patients who received medication for postoperative venous thromboembolism assessment; | — |
Countries
China
Contacts
Public ContactDanna Wu
Hainan General Hospital
Outcome results
None listed